KR101113087B1 - 수술후 오심 및 구토를 치료하는 팔로노세트론의 용도 - Google Patents
수술후 오심 및 구토를 치료하는 팔로노세트론의 용도 Download PDFInfo
- Publication number
- KR101113087B1 KR101113087B1 KR1020057014589A KR20057014589A KR101113087B1 KR 101113087 B1 KR101113087 B1 KR 101113087B1 KR 1020057014589 A KR1020057014589 A KR 1020057014589A KR 20057014589 A KR20057014589 A KR 20057014589A KR 101113087 B1 KR101113087 B1 KR 101113087B1
- Authority
- KR
- South Korea
- Prior art keywords
- palonosetron
- delete delete
- vomiting
- ponv
- surgery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44834203P | 2003-02-18 | 2003-02-18 | |
| US60/448,342 | 2003-02-18 | ||
| PCT/EP2004/001558 WO2004073714A1 (en) | 2003-02-18 | 2004-02-18 | Use of palonosetron treating post-operative nausea and vomiting |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20050121671A KR20050121671A (ko) | 2005-12-27 |
| KR101113087B1 true KR101113087B1 (ko) | 2012-02-15 |
Family
ID=32908576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020057014589A Ceased KR101113087B1 (ko) | 2003-02-18 | 2004-02-18 | 수술후 오심 및 구토를 치료하는 팔로노세트론의 용도 |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20060074101A1 (enExample) |
| EP (2) | EP1596862B1 (enExample) |
| JP (1) | JP2006517944A (enExample) |
| KR (1) | KR101113087B1 (enExample) |
| CN (1) | CN1750822A (enExample) |
| AT (1) | ATE490774T1 (enExample) |
| AU (1) | AU2004212704B2 (enExample) |
| BR (1) | BRPI0407549A (enExample) |
| CA (1) | CA2515946C (enExample) |
| CU (1) | CU23587B7 (enExample) |
| CY (1) | CY1111312T1 (enExample) |
| DE (1) | DE602004030424D1 (enExample) |
| DK (1) | DK1596862T3 (enExample) |
| EA (1) | EA013836B1 (enExample) |
| EC (1) | ECSP055970A (enExample) |
| ES (1) | ES2357769T3 (enExample) |
| GE (1) | GEP20104908B (enExample) |
| HR (1) | HRP20050709A2 (enExample) |
| IS (1) | IS7983A (enExample) |
| MX (1) | MXPA05008757A (enExample) |
| MY (1) | MY143789A (enExample) |
| NO (1) | NO20054296L (enExample) |
| NZ (1) | NZ541862A (enExample) |
| PL (1) | PL378122A1 (enExample) |
| PT (1) | PT1596862E (enExample) |
| SI (1) | SI1596862T1 (enExample) |
| TW (1) | TWI355936B (enExample) |
| UA (1) | UA96254C2 (enExample) |
| UY (1) | UY28193A1 (enExample) |
| WO (1) | WO2004073714A1 (enExample) |
| ZA (1) | ZA200506580B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015099381A1 (ko) | 2013-12-23 | 2015-07-02 | 주식회사 삼양바이오팜 | 팔로노세트론을 함유하는 약학 조성물 |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5690461B2 (ja) * | 2002-11-15 | 2015-03-25 | ヘルシン ヘルスケア ソシエテ アノニム | 化学療法誘導嘔吐を治療するためのパロノセトロン |
| JO2735B1 (en) * | 2003-01-30 | 2013-09-15 | هيلسين هيلث كير أس ايه. | Liquid pharmaceutical formulations of palonosetron |
| US8598219B2 (en) | 2003-01-30 | 2013-12-03 | Helsinn Healthcare Sa | Liquid pharmaceutical formulations of palonosetron |
| US20070196491A1 (en) * | 2006-01-27 | 2007-08-23 | Eurand, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
| JP5433236B2 (ja) * | 2006-01-27 | 2014-03-05 | アプタリス ファーマテック，インコーポレイテッド | 弱塩基性選択性セロトニン５−ｈｔ３遮断剤および有機酸を含む薬物送達系 |
| EA016455B1 (ru) * | 2006-10-24 | 2012-05-30 | Хелсинн Хелткэр С.А. | Мягкие капсулы, содержащие палоносетрона гидрохлорид, имеющие улучшенную стабильность и биологическую доступность |
| TWI429436B (zh) * | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
| US20090155363A1 (en) * | 2007-12-14 | 2009-06-18 | Todd Maibach | Methods for oral administration of active drugs |
| JP5547065B2 (ja) | 2008-05-15 | 2014-07-09 | 久光製薬株式会社 | パロノセトロンを含有する経皮吸収製剤 |
| EP2364138A2 (en) * | 2008-12-08 | 2011-09-14 | Teva Pharmaceutical Industries Ltd. | Palonosetron formulation |
| ES2432618T3 (es) * | 2009-05-20 | 2013-12-04 | Inserm (Institut National De La Santé Et De La Recherche Medicale) | Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular |
| EP2432467B1 (en) | 2009-05-20 | 2018-02-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders |
| US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
| EP2499137A1 (en) | 2009-11-13 | 2012-09-19 | Helsinn Healthcare S.A. | Palonosetron metabolites |
| EP2722045B1 (en) | 2009-11-18 | 2016-07-06 | Helsinn Healthcare SA | Compositions for treating centrally mediated nausea and vomiting |
| PE20121483A1 (es) | 2009-11-18 | 2012-12-02 | Helsinn Healthcare Sa | Composiciones para tratar nausea y vomito centralmente mediados |
| KR101368587B1 (ko) * | 2010-12-27 | 2014-03-05 | 주식회사 삼양바이오팜 | 오심 또는 구토 방지용 조성물 |
| US10071088B2 (en) | 2012-06-26 | 2018-09-11 | Precondit, Llc | Anti-nausea drug combinations |
| HRP20240453T1 (hr) | 2016-04-14 | 2024-06-21 | Sensorion | (+)-azasetron za uporabu u liječenju poremećaja uha |
| JP6768404B2 (ja) * | 2016-08-12 | 2020-10-14 | 武田テバファーマ株式会社 | パロノセトロン又はその薬学的に許容される塩を含む医薬組成物 |
| JP6705348B2 (ja) * | 2016-09-23 | 2020-06-03 | ニプロ株式会社 | 液体製剤、及び、パロノセトロンの安定性を向上する方法 |
| GB201618425D0 (en) * | 2016-11-01 | 2016-12-14 | Acacia Pharma Ltd | method |
| KR101802183B1 (ko) * | 2016-11-16 | 2017-11-28 | 주식회사 유영제약 | 팔로노세트론을 활성성분으로 함유하는 약제학적 조성물 |
| GB201702250D0 (en) | 2017-02-10 | 2017-03-29 | Acacia Pharma Ltd | Method |
| US11433021B2 (en) | 2018-01-12 | 2022-09-06 | Orion Corporation | Palonosetron for the treatment or prevention of nausea and vomiting |
| CN108703960A (zh) * | 2018-07-25 | 2018-10-26 | 无锡鑫连鑫生物医药科技有限公司 | 一种帕洛诺司琼缓释微球及其制备方法和使用方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695578A (en) | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| US4937247A (en) | 1985-04-27 | 1990-06-26 | Beecham Group P.L.C. | 1-acyl indazoles |
| DE3687080T2 (de) | 1985-04-27 | 1993-03-25 | Beecham Group Plc | Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung. |
| US5240954A (en) | 1985-06-25 | 1993-08-31 | Glaxo Group Limited | Medicaments |
| US5578628A (en) | 1985-06-25 | 1996-11-26 | Glaxo Group Limited | Medicaments for the treatment of nausea and vomiting |
| GB8516083D0 (en) | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| US4906755A (en) | 1986-11-03 | 1990-03-06 | Merrell Dow Pharmaceuticals Inc. | Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds |
| US4707484A (en) | 1986-11-25 | 1987-11-17 | Hoffmann-La Roche Inc. | Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives |
| US5011846A (en) | 1988-02-23 | 1991-04-30 | Merrell Dow Pharmaceuticals Inc. | Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof |
| GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
| US5344658A (en) * | 1989-06-28 | 1994-09-06 | Glaxo Group Limited | Process and composition using ondansetron |
| AU642178B2 (en) * | 1989-11-28 | 1993-10-14 | Roche Palo Alto Llc | New tricyclic compounds |
| US5189041A (en) | 1990-11-16 | 1993-02-23 | Syntex (U.S.A.) Inc. | Tricyclic 5-ht3 receptor antagonists |
| US5137893A (en) | 1991-03-07 | 1992-08-11 | G. D. Searle & Co. | Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof |
| US5491148A (en) | 1991-04-26 | 1996-02-13 | Syntex (U.S.A.) Inc. | Isoquinolinone and dihydroisoquinolinone 5-HT3 receptor antagonists |
| US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
| GB9305593D0 (en) | 1993-03-18 | 1993-05-05 | Smithkline Beecham Plc | Pharmaceuticals |
| US5492914A (en) | 1994-07-28 | 1996-02-20 | Syntex (U.S.A.) Inc. | 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof |
| GB9423588D0 (en) * | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
| GB9423511D0 (en) | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
| GB9625589D0 (en) * | 1996-12-10 | 1997-01-29 | Boots Co Plc | Therapeutic agents |
| US20030095926A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| US6294548B1 (en) | 1998-05-04 | 2001-09-25 | Hoffmann-La Roche Inc. | Multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride |
| EP1085888A1 (en) * | 1998-06-08 | 2001-03-28 | Advanced Medicine, Inc. | Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht 3? receptors |
| BR9914799A (pt) * | 1998-10-27 | 2001-07-10 | Alcon Lab Inc | Sistema conservante para composições farmacêuticas administráveis topicamente contendo um sabão de ácido graxo/aminoácido |
| US6196963B1 (en) * | 1999-03-02 | 2001-03-06 | Medtronic Ave, Inc. | Brachytherapy device assembly and method of use |
| AU2003237657A1 (en) * | 2002-05-24 | 2003-12-12 | Epidauros Biotechnologie Ag | Means and methods for improved treatment using "setrones" |
| JP5690461B2 (ja) * | 2002-11-15 | 2015-03-25 | ヘルシン ヘルスケア ソシエテ アノニム | 化学療法誘導嘔吐を治療するためのパロノセトロン |
| US8598219B2 (en) * | 2003-01-30 | 2013-12-03 | Helsinn Healthcare Sa | Liquid pharmaceutical formulations of palonosetron |
| JO2735B1 (en) * | 2003-01-30 | 2013-09-15 | هيلسين هيلث كير أس ايه. | Liquid pharmaceutical formulations of palonosetron |
-
2004
- 2004-02-17 TW TW093103716A patent/TWI355936B/zh not_active IP Right Cessation
- 2004-02-17 MY MYPI20040515A patent/MY143789A/en unknown
- 2004-02-18 MX MXPA05008757A patent/MXPA05008757A/es active IP Right Grant
- 2004-02-18 PL PL378122A patent/PL378122A1/pl not_active Application Discontinuation
- 2004-02-18 BR BRPI0407549-8A patent/BRPI0407549A/pt not_active Application Discontinuation
- 2004-02-18 EP EP04712041A patent/EP1596862B1/en not_active Revoked
- 2004-02-18 NZ NZ541862A patent/NZ541862A/en not_active IP Right Cessation
- 2004-02-18 UA UAA200508834A patent/UA96254C2/uk unknown
- 2004-02-18 UY UY28193A patent/UY28193A1/es not_active Application Discontinuation
- 2004-02-18 GE GEAP20048984A patent/GEP20104908B/en unknown
- 2004-02-18 CA CA002515946A patent/CA2515946C/en not_active Expired - Fee Related
- 2004-02-18 KR KR1020057014589A patent/KR101113087B1/ko not_active Ceased
- 2004-02-18 AU AU2004212704A patent/AU2004212704B2/en not_active Expired
- 2004-02-18 DK DK04712041.5T patent/DK1596862T3/da active
- 2004-02-18 WO PCT/EP2004/001558 patent/WO2004073714A1/en not_active Ceased
- 2004-02-18 ES ES04712041T patent/ES2357769T3/es not_active Expired - Lifetime
- 2004-02-18 EP EP10177400A patent/EP2258367A3/en not_active Withdrawn
- 2004-02-18 SI SI200431601T patent/SI1596862T1/sl unknown
- 2004-02-18 CN CNA2004800045134A patent/CN1750822A/zh active Pending
- 2004-02-18 PT PT04712041T patent/PT1596862E/pt unknown
- 2004-02-18 EA EA200501318A patent/EA013836B1/ru not_active IP Right Cessation
- 2004-02-18 AT AT04712041T patent/ATE490774T1/de active
- 2004-02-18 HR HR20050709A patent/HRP20050709A2/xx not_active Application Discontinuation
- 2004-02-18 JP JP2006501881A patent/JP2006517944A/ja active Pending
- 2004-02-18 DE DE602004030424T patent/DE602004030424D1/de not_active Expired - Lifetime
-
2005
- 2005-08-10 US US11/201,035 patent/US20060074101A1/en not_active Abandoned
- 2005-08-15 IS IS7983A patent/IS7983A/is unknown
- 2005-08-17 CU CU20050158A patent/CU23587B7/es active IP Right Grant
- 2005-08-17 ZA ZA200506580A patent/ZA200506580B/en unknown
- 2005-08-18 EC EC2005005970A patent/ECSP055970A/es unknown
- 2005-09-16 NO NO20054296A patent/NO20054296L/no unknown
-
2011
- 2011-03-04 CY CY20111100257T patent/CY1111312T1/el unknown
Non-Patent Citations (3)
| Title |
|---|
| Anesthesia and Analgesia, Vol. 87, No. 2, pp. 462-467, 1998. |
| British Journal of Pharmacology, Vol. 114, No. 4, pp. 860-866, 1995 |
| International Journal of Pharmaceutics, Vol. 121, pp. 95-105, 1995. |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015099381A1 (ko) | 2013-12-23 | 2015-07-02 | 주식회사 삼양바이오팜 | 팔로노세트론을 함유하는 약학 조성물 |
| US9877959B2 (en) | 2013-12-23 | 2018-01-30 | Samyang Biopharmaceuticals Corporation | Pharmaceutical composition containing palonosetron |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20050121671A (ko) | 수술후 오심 및 구토를 치료하는 팔로노세트론의 용도 | |
| US6248789B1 (en) | Administration of ketamine to manage pain and to reduce drug dependency | |
| EP1242087B1 (en) | Analgesic compositions containing buprenorphine | |
| US6538008B1 (en) | Combination of a selective NMDA NR2B antagonist and an opioid analgesic | |
| ES3064839T3 (en) | Combination of cannabidiol and buprenorphine and its use for the treatment of chronic pain | |
| KR20180016350A (ko) | 구역과 구토를 치료하기 위한 아미설프리드 및 추가의 구토 방지제의 병용 | |
| CA2230690C (en) | Administration of ketamine to manage pain and to reduce drug dependency | |
| BR112014000159A2 (pt) | composição oral, e, uso de uma composição oral | |
| US20080003280A1 (en) | Combination cough treatment compounds and method of treating common coughs | |
| PL207845B1 (pl) | Spray donosowy do dostarczania kompozycji farmaceutycznej zawierającej fentanyl i zastosowanie soli fentanylu do wytwarzania środka leczniczego | |
| MX2013003832A (es) | Formulaciones y metodos para atenuar la depresion respiratoria inducida por sobredosis de opioides. | |
| MX2010011727A (es) | Administracion oral de antagonistas opioides que actuan perifericamente. | |
| CA3025268A1 (en) | Prodrugs of phenolic trpv1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia | |
| JP2004501094A (ja) | オピオイドアゴニストの効力を増強するか、またはオピオイドアゴニストの有害な副作用を減弱するための新規な組成物および方法 | |
| JP2023027213A (ja) | 術後悪心嘔吐の救援治療 | |
| KR20140014350A (ko) | 정맥 내 투여용 이부프로펜의 투여 | |
| BR122023024228A2 (pt) | Usos de uma composição compreendendo nalbufina para o tratamento de falta de ar e dispneia | |
| McIntyre et al. | Opioid antagonists: clinical utility, pharmacology, safety, and tolerability | |
| NO309965B1 (no) | Oralt farmasøytisk antihostepreparat | |
| US20240100020A1 (en) | Medicine for relieving or eliminating protracted opioid abstinence syndrome and preparation method therefor | |
| JP2012500248A (ja) | 不安障害の治療 | |
| Karlsson et al. | The effects of prophylactic dixyrazine on postoperative vomiting after two different anaesthetic methods for squint surgery in children | |
| Bronkhorst et al. | Pholcodine: treatment options for dry cough | |
| HK1076402B (en) | Use of palonosetron for treating post-operative nausea and vomiting | |
| MILLS et al. | Opioid Side Effects |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20050808 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20090210 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20101208 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20111205 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20120131 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20120201 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| FPAY | Annual fee payment |
Payment date: 20141231 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20141231 Start annual number: 4 End annual number: 4 |
|
| J204 | Request for invalidation trial [patent] | ||
| PJ0204 | Invalidation trial for patent |
Patent event date: 20150313 Comment text: Request for Trial Patent event code: PJ02042R01D Patent event date: 20120131 Comment text: Registration of Establishment Patent event code: PJ02041E01I Appeal kind category: Invalidation Request date: 20150313 Decision date: 20160907 Appeal identifier: 2015100000950 |
|
| FPAY | Annual fee payment |
Payment date: 20160104 Year of fee payment: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20160104 Start annual number: 5 End annual number: 5 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20160404 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20120131 Comment text: Registration of Establishment Decision date: 20160907 Request date: 20160404 Appeal identifier: 2016100000843 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20160412 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20120131 Comment text: Registration of Establishment Decision date: 20160907 Request date: 20160412 Appeal identifier: 2016100000939 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2016100000843; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160404 Effective date: 20160907 Free format text: TRIAL NUMBER: 2015100000950; TRIAL DECISION FOR INVALIDATION REQUESTED 20150313 Effective date: 20160907 Free format text: TRIAL NUMBER: 2016100000939; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160412 Effective date: 20160907 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S05D Patent event date: 20160907 Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Patent event code: PJ13011S02D Patent event date: 20160907 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Appeal kind category: Confirmation of the scope of right_defensive Request date: 20160412 Decision date: 20160907 Appeal identifier: 2016100000939 Appeal kind category: Confirmation of the scope of right_defensive Request date: 20160404 Decision date: 20160907 Appeal identifier: 2016100000843 Appeal kind category: Invalidation Request date: 20150313 Decision date: 20160907 Appeal identifier: 2015100000950 |
|
| J2X1 | Appeal (before the patent court) |
Free format text: TRIAL NUMBER: 2016200007466; INVALIDATION |
|
| PJ2001 | Appeal |
Patent event date: 20160907 Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Patent event code: PJ20011S05I Patent event date: 20160907 Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Patent event code: PJ20011S02I Appeal kind category: Invalidation Decision date: 20170901 Appeal identifier: 2016200007466 Request date: 20161006 |
|
| FPAY | Annual fee payment |
Payment date: 20170102 Year of fee payment: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20170102 Start annual number: 6 End annual number: 6 |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20170428 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20120131 Comment text: Registration of Establishment Decision date: 20180420 Request date: 20170428 Appeal identifier: 2017100001358 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J206 | Request for trial to confirm the scope of a patent right | ||
| PJ0206 | Trial to confirm the scope of a patent |
Patent event code: PJ02062R01D Patent event date: 20170615 Comment text: Request for Trial Patent event code: PJ02061E01I Patent event date: 20120131 Comment text: Registration of Establishment Decision date: 20170712 Request date: 20170615 Appeal identifier: 2017100001848 Appeal kind category: Confirmation of the scope of right_defensive |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20170712 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2017100001848 Request date: 20170615 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20170712 |
|
| J2X2 | Appeal (before the supreme court) |
Free format text: TRIAL NUMBER: 2017300002253; APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION |
|
| PJ2002 | Appeal before the supreme court |
Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Patent event date: 20160907 Patent event code: PJ20021S05I Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design) Patent event date: 20160907 Patent event code: PJ20021S02I Request date: 20170925 Appeal identifier: 2017300002253 Appeal kind category: Invalidation Decision date: 20180111 |
|
| J302 | Written judgement (patent court) |
Free format text: TRIAL NUMBER: 2016200007466; JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20161006 Effective date: 20170901 |
|
| PJ1302 | Judgment (patent court) |
Patent event date: 20171130 Comment text: Written Judgment (Patent Court) Patent event code: PJ13021S01D Request date: 20161006 Decision date: 20170901 Appeal identifier: 2016200007466 Appeal kind category: Invalidation |
|
| FPAY | Annual fee payment |
Payment date: 20180110 Year of fee payment: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20180110 Start annual number: 7 End annual number: 7 |
|
| J221 | Remand (intellectual property tribunal) |
Free format text: TRIAL NUMBER: 2018130000011; REMAND (INTELLECTUAL PROPERTY TRIBUNAL) FOR INVALIDATION |
|
| J303 | Written judgement (supreme court) |
Free format text: TRIAL NUMBER: 2017300002253; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20170925 Effective date: 20180111 |
|
| PJ1303 | Judgment (supreme court) |
Comment text: Written Judgment (Supreme Court) Patent event date: 20180130 Patent event code: PJ13031S01D Decision date: 20180111 Appeal kind category: Invalidation Request date: 20170925 Appeal identifier: 2017300002253 |
|
| PJ2201 | Remand (intellectual property tribunal) |
Request date: 20180130 Appeal kind category: Invalidation Appeal identifier: 2018130000011 Decision date: 20180228 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2018130000011; TRIAL DECISION FOR INVALIDATION REQUESTED 20180130 Effective date: 20180228 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S09D Patent event date: 20180228 Comment text: Trial Decision on Final Judgment on Revocation Appeal kind category: Invalidation Request date: 20180130 Decision date: 20180228 Appeal identifier: 2018130000011 |
|
| EXTG | Ip right invalidated | ||
| PC2102 | Extinguishment |
Termination category: Others Termination date: 20180515 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20180420 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2017100001358 Request date: 20170428 Appeal kind category: Confirmation of the scope of right_defensive Decision date: 20180420 |
|
| G170 | Re-publication after modification of scope of protection [patent] | ||
| PG1701 | Publication of correction |
Publication date: 20180521 |